Seismic Therapeutic
Alex Pellerin has worked in the scientific field since 2007. Alex began their career as a Research Tech at the Immune Disease Institute and then moved on to become an Associate Scientist at Tempero Pharmaceuticals (a GSK company) in 2011. In the same year, they joined Biogen as a Senior Scientist and in 2022 they were appointed as Principal Scientist at Seismic Therapeutic.
Alex Pellerin attended Bowdoin College from 2002 to 2006 and subsequently completed their Doctor of Philosophy - PhD in Molecular Translational Medicine from Boston University in 2021.
Seismic Therapeutic
1 followers
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.